CLINICAL_TRIALS
trial_result
· 2011-08-30
Clinical Trial Update: Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II [Phase 3]
Summary
Phase 3 trial update reporting efficacy and safety data for oral bosentan in patients with pulmonary arterial hypertension class II.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Actelion | Conditions: Pulmonary Hypertension | Phase 3 | Status: COMPLETED